Bristol-Myers Squibb Historical PE Ratio image   This BMY PE ratio history page last updated 4/11/2024
Bristol-Myers Squibb Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q4 2023
2/2/2024
48.711.706.807.2
Q3 2023
10/26/2023
52.972.008.006.6
Q2 2023
7/27/2023
60.731.757.008.7
Q1 2023
4/27/2023
67.612.058.208.2
Q4 2022
2/2/2023
72.771.827.2810.0
Q3 2022
10/25/2022
72.771.997.969.1
Q2 2022
7/27/2022
74.811.937.729.7
Q1 2022
4/29/2022
75.271.967.849.6
Q4 2021
2/4/2022
64.991.837.328.9
Q3 2021
10/27/2021
56.492.008.007.1
Q2 2021
7/28/2021
68.731.937.728.9
Q1 2021
4/29/2021
62.891.746.969.0
Q4 2020
2/4/2021
61.561.465.8410.5
Q3 2020
11/5/2020
63.751.636.529.8
Q2 2020
8/6/2020
61.331.636.529.4
Q1 2020
5/7/2020
61.041.726.888.9
Q4 2019
2/6/2020
67.101.224.8813.8
Q3 2019
10/31/2019
57.371.174.6812.3
Q2 2019
7/25/2019
45.401.184.729.6
Q1 2019
4/25/2019
45.641.104.4010.4
Q4 2018
1/24/2019
49.020.943.7613.0
Q3 2018
10/25/2018
49.211.094.3611.3
Q2 2018
7/26/2018
57.921.014.0414.3
Q1 2018
4/26/2018
52.040.943.7613.8
Q4 2017
2/5/2018
60.960.682.7222.4
Q3 2017
10/26/2017
60.950.753.0020.3
Q2 2017
7/27/2017
54.240.742.9618.3
Q1 2017
4/27/2017
55.670.843.3616.6
Q4 2016
1/26/2017
46.820.632.5218.6
Q3 2016
10/27/2016
51.960.773.0816.9
Q2 2016
7/28/2016
74.660.692.7627.1
Q1 2016
4/28/2016
72.260.742.9624.4
Q4 2015
1/28/2016
61.160.381.5240.2
Q3 2015
10/27/2015
66.800.391.5642.8
Q2 2015
7/23/2015
68.240.532.1232.2
Q1 2015
4/28/2015
64.540.712.8422.7
Q4 2014
1/27/2015
61.990.461.8433.7
Q3 2014
10/24/2014
53.630.451.8029.8
Q2 2014
7/24/2014
49.460.481.9225.8
Q1 2014
4/29/2014
49.320.461.8426.8
Q4 2013
1/24/2014
50.940.512.0425.0
Q3 2013
10/23/2013
48.960.461.8426.6
Q2 2013
7/25/2013
43.930.441.7625.0
Q1 2013
4/25/2013
40.220.411.6424.5
Q4 2012
1/24/2013
35.810.471.8819.0
Q3 2012
10/24/2012
33.050.411.6420.2
Q2 2012
7/25/2012
34.950.481.9218.2
Q1 2012
4/25/2012
34.290.642.5613.4
Bristol-Myers Squibb PE History Chart
PeriodPriceAdj. EPSTTMPE
Q4 2023
2/2/2024
48.711.707.506.5
Q3 2023
10/26/2023
52.972.007.627.0
Q2 2023
7/27/2023
60.731.757.618.0
Q1 2023
4/27/2023
67.612.057.798.7
Q4 2022
2/2/2023
72.771.827.709.5
Q3 2022
10/25/2022
72.771.997.719.4
Q2 2022
7/27/2022
74.811.937.729.7
Q1 2022
4/29/2022
75.271.967.729.7
Q4 2021
2/4/2022
64.991.837.508.7
Q3 2021
10/27/2021
56.492.007.137.9
Q2 2021
7/28/2021
68.731.936.7610.2
Q1 2021
4/29/2021
62.891.746.469.7
Q4 2020
2/4/2021
61.561.466.449.6
Q3 2020
11/5/2020
63.751.636.2010.3
Q2 2020
8/6/2020
61.331.635.7410.7
Q1 2020
5/7/2020
61.041.725.2911.5
Q4 2019
2/6/2020
67.101.224.6714.4
Q3 2019
10/31/2019
57.371.174.3913.1
Q2 2019
7/25/2019
45.401.184.3110.5
Q1 2019
4/25/2019
45.641.104.1411.0
Q4 2018
1/24/2019
49.020.943.9812.3
Q3 2018
10/25/2018
49.211.093.7213.2
Q2 2018
7/26/2018
57.921.013.3817.1
Q1 2018
4/26/2018
52.040.943.1116.7
Q4 2017
2/5/2018
60.960.683.0120.3
Q3 2017
10/26/2017
60.950.752.9620.6
Q2 2017
7/27/2017
54.240.742.9818.2
Q1 2017
4/27/2017
55.670.842.9319.0
Q4 2016
1/26/2017
46.820.632.8316.5
Q3 2016
10/27/2016
51.960.772.5820.1
Q2 2016
7/28/2016
74.660.692.2033.9
Q1 2016
4/28/2016
72.260.742.0435.4
Q4 2015
1/28/2016
61.160.382.0130.4
Q3 2015
10/27/2015
66.800.392.0932.0
Q2 2015
7/23/2015
68.240.532.1531.7
Q1 2015
4/28/2015
64.540.712.1030.7
Q4 2014
1/27/2015
61.990.461.8533.5
Q3 2014
10/24/2014
53.630.451.9028.2
Q2 2014
7/24/2014
49.460.481.9125.9
Q1 2014
4/29/2014
49.320.461.8726.4
Q4 2013
1/24/2014
50.940.511.8228.0
Q3 2013
10/23/2013
48.960.461.7827.5
Q2 2013
7/25/2013
43.930.441.7325.4
Q1 2013
4/25/2013
40.220.411.7722.7
Q4 2012
1/24/2013
35.810.472.0017.9
Q3 2012
10/24/2012
33.050.41NANA
Q2 2012
7/25/2012
34.950.48NANA
Q1 2012
4/25/2012
34.290.64NANA
Quotes delayed 20 minutes

Email EnvelopeFree BMY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Bristol-Myers Squibb (BMY) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

BNGO PE Ratio History
BOLT PE Ratio History
BPMC PE Ratio History
BPTH PE Ratio History
BRKR PE Ratio History
BRTX PE Ratio History
BSGM PE Ratio History
BSX PE Ratio History
BTAI PE Ratio History
BTCY PE Ratio History
How should the BMY historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Bristol-Myers Squibb. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this BMY Historical PE Ratio page.

What is the average historical PE for BMY based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The BMY historical PE ratio using the annualized quarterly earnings method works out to 17.3.

What is the average historical PE for BMY based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The BMY historical PE ratio using the TTM earnings method works out to 17.8.

What is the average historical PE for BMY based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The BMY historical PE ratio using the annualized median TTM earnings method works out to 7.52.

On this page we presented the Bristol-Myers Squibb Historical PE Ratio information for Bristol-Myers Squibb' stock. The average BMY historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 17.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average BMY historical PE based on this TTM earnings result method is 17.8.

Let's now compare this BMY historical PE result, against the recent PE: when this page was posted on 4/10/2024, the most recent closing price for BMY had been 50.29, and the most recent quarterly earnings result, annualized, was 6.8. Meanwhile, the most recent TTM earnings summed to 7.5. From these numbers, we calculate the recent BMY PE on 4/10/2024 based on annualized quarterly EPS was 7.4. Based on BMY's history, that recent PE is low relative to the historical average, with the recent PE 57.2% lower than the historical average PE across our data set for Bristol-Myers Squibb. Looking at the recent BMY PE on 4/10/2024 based on TTM EPS, we calculate the ratio at 6.7. Based on BMY's history, that recent PE is low relative to the historical average, with the recent PE 62.4% lower than the average PE across our Bristol-Myers Squibb data set with TTM EPS used in the calculation at each period.

Another interesting BMY historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for BMY, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for BMY, we start with the past four EPS numbers and we first sort them from lowest to highest: 1.70, 1.75, 2.00, and 2.05. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 1.75 and 2.00 — which gives us the median of 1.88. Basically the way to think about this 1.88 number is this: for the trailing four earnings reports, 1.88 marks the "middle ground" number where BMY has reported a value higher than 1.88 half the time, and has reported a value lower than 1.88 half the time. Annualizing that median value then gets us to 7.52/share, which we use as the denominator in our next PE calculation. With 50.29 as the numerator (as of 4/10/2024), the calculation is then 50.29 / 7.52 = 6.7 as the BMY PE ratio as of 4/10/2024, based on that annualized median value we calculated.

For self directed investors doing their due diligence on BMY or any other given stock, valuation analysis for BMY can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Bristol-Myers Squibb PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for BMY. Thanks for visiting, and the next time you need to research BMY Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: DTH market cap history, ROIV Average Annual Return, BREW Options Chain.

 

Bristol-Myers Squibb Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.